Wuxi sets up drug supplier network to ease pharma sourcing

By Staff Reporter

- Last updated on GMT

Wuxi sets up drug supplier network to ease pharma sourcing

Related tags Wuxi apptec Pharmacology

WuxI AppTec has a chemical trading network designed to help drug manufacturers source more efficiently.

The idea is to provide pharmaceutical firms with a list of chemical suppliers that have rated according to a system developed by Wuxi over the past 15 years.

At present the network – operated by Wuxi’s LabNetwork subsidiary - is made up of eight China-based suppliers, however the aim is to allow more manufacturers to join in due course.

Drug industry users are able to assess the suppliers via an online eCommerce platform that also allows them to place and manage orders according to LabNetwork head Xuanjia Peng.

"WuXi AppTec has always been dedicated to creating an open platform for innovation and technology, and LabNetwork is the ideal channel through which we continue this quest. We spare no efforts to provide high quality compounds to global end-users in pharmaceutical discovery and help them to speed up their research​."

He told us that: "We assess the suppliers depend on the historical KPIs they serviced WuXi, like quality, on time delivery, SKUs etc.​"

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...